Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate 01/03/2019 Medications, Saint-Herblain (France), December 21, 2018 - Valneva SE ("Valneva"), a biotech company developing and commercializing...
FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease 11/19/2018 Medications, ROCKVILLE, Md., Nov. 14, 2018 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology...
Lead in hair dyes must go: FDA 10/31/2018 Health News, (HealthDay)—The U.S. Food and Drug Administration on Tuesday said that hair dyes can no longer...
FDA Approves Xofluza 10/24/2018 Medications, October 24, 2018 -- Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil)...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years 10/17/2018 Medications, DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global...
FDA Approves Revcovi 10/06/2018 Medications, GAITHERSBURG, Md.--(BUSINESS WIRE) October 05, 2018 --Leadiant Biosciences, Inc. today announced that the Food and...
FDA: montelukast tablet bottles recalled 09/05/2018 Medications, (HealthDay)—Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because...
FDA Approves Takhzyro 08/24/2018 Medications, August 23, 2018 -- The U.S. Food and Drug Administration today approved Takhzyro (lanadelumab), the...
FDA Approves Inveltys 08/24/2018 Medications, WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 23, 2018-- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the...
FDA Approves Brain Stimulation Device for OCD 08/17/2018 Health News, FRIDAY, Aug. 17, 2018 -- A brain stimulation device to treat obsessive-compulsive disorder (OCD) has...